MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,525 Cr | ₹2,399 Cr | ₹1,671 Cr | ₹1,975 Cr | ₹1,692 Cr |
| Adjustment | ₹602 Cr | ₹212 Cr | ₹298 Cr | ₹31 Cr | ₹-5.66 Cr |
| Changes In working Capital | ₹-146 Cr | ₹-18 Cr | ₹167 Cr | ₹-586 Cr | ₹-95 Cr |
| Cash Flow after changes in Working Capital | ₹2,980 Cr | ₹2,594 Cr | ₹2,136 Cr | ₹1,419 Cr | ₹1,591 Cr |
| Cash Flow from Operating Activities | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr |
| Cash Flow from Investing Activities | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr |
| Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
| Net Cash Inflow / Outflow | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr | ₹-93 Cr |
| Opening Cash & Cash Equivalents | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr | ₹220 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | ₹-9.40 Cr | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹67 Cr | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹1.31 Cr | ₹1.17 Cr | ₹2.32 Cr | ₹0.48 Cr | ₹0.38 Cr |
| Closing Cash & Cash Equivalent | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹90,489.9 Cr | 0.8% | -3% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.8% |
-3% |
-26.9% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses